The Spanish Agency for Medicines and Health Products (Aemps) has issued an alert upon detecting the presence of bacteria in a series of batches of an antigen test for Covid-19.
After finding contamination by Pseudomonas aeruginosa in the extraction solution of four batches, they have decided to withdraw all distributed batches from pharmacies as well as to immediately cease their marketing.
This is the rapid self-diagnosis hypertensive test Rapid COVID-19 Antigen Test (Coloidal Gold)/Saliva, manufactured in Anbio (Xiamen) Biotechnology Co., Ltd. (Porcelain).
In June 2022, Aemps reported the presence of this bacterium in very large quantities of the city's product and proceeded to eliminate it, but the recent appearance of an infected quadruple raised to the body could be completely eliminated.
Removal of locks from pharmacies and distribution
"Aemps has requested the definitive voluntary cessation of the commercialization of the product, as well as the withdrawal of all batches of the product from the Spanish market, both from the manufacturer and from the distributors identified in the commercialization registry," they explain in the statement released to the government. portal.
"Likewise, it requests the rest of the possible economic agents that have distributed the product in our country to take the appropriate voluntary measures to cease marketing and withdraw the product from the Spanish market," it adds, in an appeal that includes those citizens who have purchased the product in question.
